Sun Pharma Advanced Research Company reports consolidated net loss of Rs 79.51 crore in the December 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 79.51 crore in the quarter ended December 2024 as against net loss of Rs 99.65 crore during the previous quarter ended December 2023. Sales rose 7.58% to Rs 14.91 crore in the quarter ended December 2024 as against Rs 13.86 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 14.91 | 13.86 | 8 |
| OPM % | -494.23 | -740.40 | - |
| PBDT | -76.30 | -96.49 | 21 |
| PBT | -79.44 | -99.65 | 20 |
| NP | -79.51 | -99.65 | 20 |
